Type a term, then click a field below.
Search | simple search
You've reached a pubget topic page. Below are the latest papers on this topic, with subtopics on the left.
keywords > Organic Chemicals > Carboxylic Acids > Acids, Carbocyclic > Phenylacetates > Diphenylacetic Acids > Benzilates
Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure.
Randomized, double-blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder.
Anesthesia increases in vivo N-([18F]fluoroethyl)piperidinyl benzilate binding to the muscarinic cholinergic receptor.
Analysis of pharmacological effects of drugs used for treatment of urinary disturbance based on anticholinergic and smooth muscle-relaxing effects.
Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
Binding activities by propiverine and its N-oxide metabolites of L-type calcium channel antagonist receptors in the rat bladder and brain.
Update on drugs for overactive bladder syndrome.
Determination of propiverine and its metabolites in rat samples by liquid chromatography-tandem mass spectrometry.
A standardised mini pig model for in vivo investigations of anticholinergic effects on bladder function and salivation
[Does alpha1-blocker provide additional improvement of quality-of-life in patients with overactive bladder?--a multi-center prospective randomized trial between anti-cholinergic (propiverine chloride) with and without alpha1-blocker (urapidil)].
Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents.
Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
[The effects of metacine and anapriline course therapy on the morphofunctional changes in the gastric mucosa of patients with chronic gastroduodenitis].
Treatment of the overactive bladder syndrome with muscarinic receptor antagonists: a matter of metabolites?
Propiverine and metabolites: differences in binding to muscarinic receptors and in functional models of detrusor contraction.
Naftopidil monotherapy vs naftopidil and an anticholinergic agent combined therapy for storage symptoms associated with benign prostatic hyperplasia: A prospective randomized controlled study.
A gap junction blocker inhibits isolated whole bladder activity in normal rats and rats with partial bladder outlet obstruction.
Efficacy, tolerability and safety of propiverine hydrochloride in children and adolescents with congenital or traumatic neurogenic detrusor overactivity--a retrospective study.
[Propiverine hydrochloride improved correlatively subjective QOL and objective findings in Japanese patients with urinary frequency and/or incontinence].